TSE:ONC

Oncolytics Biotech (ONC) Stock Price, News & Analysis

Oncolytics Biotech logo
C$14.90 -0.20 (-1.32%)
As of 09/3/2025

About Oncolytics Biotech Stock (TSE:ONC)

Key Stats

Today's Range
C$14.90
▼
C$14.90
50-Day Range
C$14.90
▼
C$14.90
52-Week Range
C$0.44
▼
C$2.08
Volume
280 shs
Average Volume
169,589 shs
Market Capitalization
C$1.50 billion
P/E Ratio
N/A
Dividend Yield
0.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONC Stock News Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

Oncolytics Biotech's stock was trading at C$14.90 at the beginning of 2026. Since then, ONC stock has increased by 0.0% and is now trading at C$14.90.

Oncolytics Biotech Inc. (TSE:ONC) announced its quarterly earnings data on Tuesday, November, 12th. The company reported C($0.12) earnings per share for the quarter, missing the consensus estimate of C($0.11) by C$0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncolytics Biotech investors own include Oncolytics Biotech (ONCY), Sorrento Therapeutics (SRNE), Enbridge (ENB), Organigram (OGI), ProMetic Life Sciences (PLI), Air Canada (AC) and BlackBerry (BB).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:ONC
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$27.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-189.05%
Return on Assets
-71.33%

Debt

Debt-to-Equity Ratio
17.78
Current Ratio
2.82
Quick Ratio
8.86

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$3.53 per share
Price / Cash Flow
4.22
Book Value
C$0.08 per share
Price / Book
190.47

Miscellaneous

Outstanding Shares
100,361,000
Free Float
N/A
Market Cap
C$1.50 billion
Optionable
Not Optionable
Beta
0.80
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (TSE:ONC) was last updated on 9/3/2025 by MarketBeat.com Staff.
From Our Partners